| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f9533575751b2321d1ec25271480dc9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 |
| filingDate |
2020-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2023-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3898e994fecb4195502928b583001f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ae7cd65c9385442ed9770edd802c251
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dbf856aa11b38cd9a45c315f9f0fdad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e7926c9ae1f966da09f5d1ca5d92cea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a41dfe2f57022d1ded3004129c865dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4416a1e74b2990ff2252dfba24b7aef3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87bb359809cd580e94a4a21e71ad3a5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2691566d509df15bc4953afc450ebbd1 |
| publicationDate |
2023-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11584756-B2 |
| titleOfInvention |
Heterocyclic compounds as BET inhibitors |
| abstract |
Novel bromodomain and extraterminal domain (BET) inhibitors and to therapeutic methods of treating conditions and diseases using these novel BET inhibitors are provided. |
| priorityDate |
2019-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |